CD66c and CD7 were the most frequent aberrant markers in B-cell acute lymphoblastic leukemia and acute myeloid leukemia, respectively, and the frequency was higher as compared to the literature. This evidence concerns the gene CD7 and B-cell acute lymphoblastic leukemia.